000 01161 a2200301 4500
005 20250516134534.0
264 0 _c20130410
008 201304s 0 0 eng d
022 _a1460-2156
024 7 _a10.1093/brain/awt022
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aUshe, Mwiza
245 0 0 _aSex, drugs and Parkinson's disease.
_h[electronic resource]
260 _bBrain : a journal of neurology
_cFeb 2013
300 _a371-3 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAnimals
650 0 4 _aAntiparkinson Agents
_xadverse effects
650 0 4 _aDisruptive, Impulse Control, and Conduct Disorders
_xchemically induced
650 0 4 _aDopamine
_xmetabolism
650 0 4 _aDopamine Agonists
_xadverse effects
650 0 4 _aHumans
650 0 4 _aParkinson Disease
_xdrug therapy
650 0 4 _aSexual Behavior
_xdrug effects
700 1 _aPerlmutter, Joel S
773 0 _tBrain : a journal of neurology
_gvol. 136
_gno. Pt 2
_gp. 371-3
856 4 0 _uhttps://doi.org/10.1093/brain/awt022
_zAvailable from publisher's website
999 _c22508010
_d22508010